rs1800629

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The variant allele was found at a frequency of 0.131 in 474,386 control chromosomes in the GnomAD database, including 4,807 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as drug response (★★★).

Frequency

Genomes: 𝑓 0.14 ( 1582 hom., cov: 31)
Exomes 𝑓: 0.13 ( 3225 hom. )

Consequence

Unknown

Scores

2

Clinical Significance

drug response reviewed by expert panel U:2O:9

Conservation

PhyloP100: 0.0180

Publications

3734 publications found
Variant links:

Genome browser will be placed here

ACMG classification

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.168 is higher than 0.05.

Variant Effect in Transcripts

 

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt

There are no transcript annotations for this variant.

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt

There are no transcript annotations for this variant.

Frequencies

GnomAD3 genomes
AF:
0.138
AC:
20989
AN:
152008
Hom.:
1578
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.127
Gnomad AMI
AF:
0.219
Gnomad AMR
AF:
0.0872
Gnomad ASJ
AF:
0.0839
Gnomad EAS
AF:
0.0681
Gnomad SAS
AF:
0.0691
Gnomad FIN
AF:
0.123
Gnomad MID
AF:
0.120
Gnomad NFE
AF:
0.171
Gnomad OTH
AF:
0.126
GnomAD2 exomes
AF:
0.116
AC:
17554
AN:
150892
AF XY:
0.118
show subpopulations
Gnomad AFR exome
AF:
0.119
Gnomad AMR exome
AF:
0.0594
Gnomad ASJ exome
AF:
0.0762
Gnomad EAS exome
AF:
0.0896
Gnomad FIN exome
AF:
0.120
Gnomad NFE exome
AF:
0.163
Gnomad OTH exome
AF:
0.124
GnomAD4 exome
AF:
0.128
AC:
41363
AN:
322260
Hom.:
3225
Cov.:
0
AF XY:
0.125
AC XY:
22845
AN XY:
183234
show subpopulations
African (AFR)
AF:
0.123
AC:
1151
AN:
9350
American (AMR)
AF:
0.0609
AC:
1749
AN:
28742
Ashkenazi Jewish (ASJ)
AF:
0.0803
AC:
903
AN:
11246
East Asian (EAS)
AF:
0.0760
AC:
806
AN:
10602
South Asian (SAS)
AF:
0.0760
AC:
4580
AN:
60236
European-Finnish (FIN)
AF:
0.134
AC:
1878
AN:
14012
Middle Eastern (MID)
AF:
0.170
AC:
481
AN:
2824
European-Non Finnish (NFE)
AF:
0.163
AC:
27754
AN:
169932
Other (OTH)
AF:
0.135
AC:
2061
AN:
15316
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.445
Heterozygous variant carriers
0
1608
3216
4824
6432
8040
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
146
292
438
584
730
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.138
AC:
20992
AN:
152126
Hom.:
1582
Cov.:
31
AF XY:
0.132
AC XY:
9824
AN XY:
74368
show subpopulations
African (AFR)
AF:
0.127
AC:
5287
AN:
41508
American (AMR)
AF:
0.0870
AC:
1330
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.0839
AC:
291
AN:
3470
East Asian (EAS)
AF:
0.0683
AC:
353
AN:
5168
South Asian (SAS)
AF:
0.0690
AC:
332
AN:
4814
European-Finnish (FIN)
AF:
0.123
AC:
1299
AN:
10604
Middle Eastern (MID)
AF:
0.109
AC:
32
AN:
294
European-Non Finnish (NFE)
AF:
0.171
AC:
11606
AN:
67968
Other (OTH)
AF:
0.124
AC:
262
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
921
1841
2762
3682
4603
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
232
464
696
928
1160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.156
Hom.:
6420
Bravo
AF:
0.135
Asia WGS
AF:
0.0700
AC:
243
AN:
3478

ClinVar

ClinVar submissions as Germline
Significance:drug response
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
Susceptibility to severe coronavirus disease (COVID-19) (1)
-
1
-
Susceptibility to severe coronavirus disease (COVID-19) due to high plasma levels of TNF, TNFR, and/or TNFR4 (1)
-
-
-
Endometriosis (1)
-
-
-
etanercept response - Efficacy (1)
-
-
-
HUMAN IMMUNODEFICIENCY VIRUS DEMENTIA, SUSCEPTIBILITY TO (1)
-
-
-
Inherited susceptibility to asthma (1)
-
-
-
Malaria, cerebral, susceptibility to (1)
-
-
-
MIGRAINE WITHOUT AURA, SUSCEPTIBILITY TO (1)
-
-
-
Psoriatic arthritis, susceptibility to (1)
-
-
-
SEPTIC SHOCK, SUSCEPTIBILITY TO (1)
-
-
-
Systemic lupus erythematosus, susceptibility to (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
2.9
DANN
Benign
0.48
PhyloP100
0.018
PromoterAI
-0.028
Neutral

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1800629; hg19: chr6-31543031; API